FFCP PHASE1:Hg19::chr1:211848955..211848981,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p1@NEK2 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_NEK2_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | 0bp_to_ENST00000366999, NM_001204182, NM_001204183, NM_002497, uc001hiq.1, uc001hir.1, uc001his.3, uc001hit.1_5end |
EntrezGene: | NEK2 |
HGNC: | 7745 |
UniProt: | P51955 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@NEK2 |
---|
0
10
20
30
40
50
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 2.38e-62 | 235 |
disease of cellular proliferation | 4.29e-61 | 239 |
cell type cancer | 4.81e-34 | 143 |
organ system cancer | 5.70e-27 | 137 |
carcinoma | 3.36e-25 | 106 |
hematologic cancer | 9.95e-20 | 51 |
immune system cancer | 9.95e-20 | 51 |
leukemia | 2.15e-14 | 39 |
myeloid leukemia | 5.57e-11 | 31 |
germ cell and embryonal cancer | 1.54e-07 | 22 |
Showing 1 to 10 of 11 entries